COVID-19 Resources

Insights from PreScouter's experts to support decision makers and the public during the pandemic.

Operating Workplaces: How to keep manufacturing during the COVID-19 pandemic

Following best practices for social distancing, hygiene and disinfection is crucial for manufacturing-centric workplaces. By following the recommendations and guidelines presented here, businesses can ensure...



Season 1, Episode 2 – Mobile-Angel

– In this episode, we’ll take a closer look at how a truly democratic organization can...
Sample Briefing

When will the COVID-19 pandemic end?

– In this report, we’ll cover what companies can do sustain, and even grow, in this...
Sample Briefing

Manufacturing challenges of critical COVID-19 medical equipment and how the industry is responding

– The COVID-19 pandemic has very clearly shown that most of the world is lagging in...
Sample Briefing

Emerging disinfection technologies for manufacturers and consumers

– In light of the current COVID-19 pandemic, we are seeing an upsurge in novel technologies...



Covid-19: Impacts & sufferings in the global auto industry

– Experts and analysts say the coronavirus pandemic has crippled the global economy worse than the...

What novel software applications are enabling remote work during the COVID-19 crisis?

– During this global pandemic, we are bombarded with more questions than answers on a daily...
White Paper

Additive Manufacturing in Consumer Packaged Goods

– Consumer Packaged Goods (CPG) is one of many major industries on which 3D-printing technologies will...

Latest updates on telemedicine: Exactly what the COVID-19 pandemic needs

– The current outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome...

Working from home tips from PreScouter: How to maintain productivity amid the coronavirus pandemic

– In December 2019, a novel coronavirus, COVID-19, appeared in the city of Wuhan, China. It...
Sample Briefing

COVID-19: How R&D Responded & What We Learned for Future Outbreaks

– As there is no approved treatment for COVID-19, the current standard of treatment has been...
Sample Briefing

COVID-19: Current Response

– In this Intelligence Brief, Prescouter discusses the epidemiology, current standards for treatment, diagnostics, and prevention...

Nanomedicine – Using smart nanoparticles for better drug delivery

– Nanoparticles are poorly delivered Nanoparticles have steadily been making their way into bio-medicine or nanomedicine...



Canadian researchers develop biodegradable medical mask for COVID-19

– Researchers in the BioProducts Institute at the University of British Columbia have designed what could...

Moderna Announces Positive Phase 1 Data for its mRNA Vaccine Against Novel Coronavirus

– Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2),...

Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests

– The U.S. Food and Drug Administration has authorized an at-home sample collection kit that can...

Anti-SARS-CoV-2 Antibody Inhibits In Vitro Virus Infection In Preclinical Studies

– Sorrento Therapeutics, Inc. announced today that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2...

Novavax to Receive up to $38M Funding for COVID-19 Vaccine Development and Manufacturing

– Novavex, Inc. announces $384 million in extra funding from CEPI to advance clinical development of...

Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD™ Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19)

– Sorrento Therapeutics, Inc. teams up with Mount Sinai Health System to investigate and develop antibody...

Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients

– Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital submit IND for a Phase...

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus

– Moderna announces 10 year strategic collaboration with Lonza to enable larger scale manufacture of Moderna’s...

Never miss an insight

Get insights delivered right to your inbox

You have successfully subscribed to our newsletter.

Too many subscribe attempts for this email address.